In Order Shutting Down New York Supplement Firm, Federal Judge Also Criticizes FDA’s Calculations
Executive Summary
Judge ordering permanent injunction against Confidence USA on a complaint filed in 2019 questioned FDA's calculations for requiring the firm to recall and destroy all products it had distributed since February 2018.
You may also be interested in...
Wellness Industry News: GMP Complaint Against Confidence USA, Crown Labs Expands Again, More
FDA seeks injunction against Confidence USA; Crown Labs expands again; CHPA, PCPC say Environmental Working Group "irresponsibly misrepresents” evidence on sunscreen safety; Kratom Information & Resource Center says 92% of news about kratom published since February was ‘unfair and unbalanced’; more news.
FDA Drops Access Restrictions On Generic OTC Emergency Contraceptives
In a recent letter to drug firms, FDA rejects Plan B One-Step manufacturer Teva’s requests to restrict sales and labeling of generic equivalents. Labeling for the generics will not prevent consumers under 17 from buying the products nor require retailers to ask consumers for proof of age.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.